Danaher Releases 2022 Sustainability Report and Announces New Greenhouse Gas Emissions Reduction Target Medical Device Investing
Seasonal Affective Disorder Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022 Pharmaceutical Investing
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 26, 2022 Medical Device Investing
Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference Pharmaceutical Investing
SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY Pharmaceutical Investing
ALR Technologies Announces Update to Singapore Migration Merger and GluCurve Pet CGM Commercialization Medical Device Investing
Thermo Fisher Scientific to Source Half of its U.S. Electricity Needs from Wind Power Purchase with Enel North America Medical Device Investing
Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations Pharmaceutical Investing
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company Pharmaceutical Investing
Knight Therapeutics Inc. places No. 22 on The Globe and Mail's fourth-annual ranking of Canada's Top Growing Companies Pharmaceutical Investing
